This retrospective analysis compares the efficacy of three endovascular treatment modalities in the treatment of vascular access stenoses: 1) plain-balloon angioplasty + drug coated balloon ...
VentureMed Group, Inc., a leading medical device company specializing in vessel preparation and access management technologies for the treatment of peripheral arterial disease (PAD) and arteriovenous ...
Medical Device Network on MSN
VentureMed raises $28m for vessel prep system advancement
VentureMed plans to use the latest funding tranche to expand the clinical programmes for its FLEX VP system in adjacent vascular settings.
Honolulu, HI | April 18, 2023—Findings from an award-winning Scientific Online Poster presented during the 2023 ARRS Annual Meeting on the island of Oahu determined that assessing the vascularity and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback